Parmax Pharma informs about standalone financial results

16 Mar 2017 Evaluate

Parmax Pharma has informed about Standalone Financial Results & Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

29.90 1.38 (4.84%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×